TAUNS Laboratories,Inc. 197AShort Interest

Estimated short interest in TAUNS Laboratories,Inc. (197A) is 2.30% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: UBS AG.

Standard Market(Domestic) Pharmaceutical Pharmaceutical
Estimated short interest
2.30%
±0.00%
Estimated position (shares)
2,460,400
As of 2026-11-18
Holders (0.5% or more)
1 firms
154 reports

Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 2 institutions that fell below 0.5%. How estimates are calculated

Disclosure History Summary

First disclosure2025-01-08
Latest disclosure2026-11-10 (UBS AG, 2.30%)
Reporting institutions3 firms (154 reports)
Peak estimated short interest3.66% (2026-04-23, 3 holders)

Short Interest Trend Last 5 years, by institution, % of shares outstanding

Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 3 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.

  • UBS AG
  • GOLDMAN SACHS INTERNATIONAL
  • Morgan Stanley MUFG Securities Co., Ltd.
2.30%
Estimated short interest, 2026-11-18
UBS AG2.30%

Current Positions by Short Seller Latest report of each holder

Last report Short seller Position (shares) Ratio Change Status
2026-11-10 UBS AG Position 2,460,400 shares Ratio 2.30% ▲0.10% +105,000 Holding
2026-08-18 GOLDMAN SACHS INTERNATIONAL Position 519,200 shares Ratio 0.48% ▼0.02% −22,100 Below 0.5%
2026-09-14 Morgan Stanley MUFG Securities Co., Ltd. Position 473,524 shares Ratio 0.44% ▼0.15% −164,300 Below 0.5%

Disclosure History 154 in total

Trade date Short seller Position (shares) Ratio Change Note
2026-11-10 UBS AG Position 2,460,400 shares Ratio 2.30% ▲0.10% +105,000 —
2026-10-07 UBS AG Position 2,355,400 shares Ratio 2.20% ▲0.02% +24,300 —
2026-09-29 UBS AG Position 2,331,100 shares Ratio 2.18% ▼0.11% −118,900 —
2026-09-16 UBS AG Position 2,450,000 shares Ratio 2.29% ▼0.09% −99,200 —
2026-09-14 Morgan Stanley MUFG Securities Co., Ltd. Position 473,524 shares Ratio 0.44% ▼0.15% −164,300 Below 0.5%
2026-09-04 Morgan Stanley MUFG Securities Co., Ltd. Position 637,824 shares Ratio 0.59% ▼0.09% −92,000 —
2026-08-27 Morgan Stanley MUFG Securities Co., Ltd. Position 729,824 shares Ratio 0.68% ▼0.02% −18,600 —
2026-08-25 Morgan Stanley MUFG Securities Co., Ltd. Position 748,424 shares Ratio 0.70% ▲0.10% +106,200 —
2026-08-18 GOLDMAN SACHS INTERNATIONAL Position 519,200 shares Ratio 0.48% ▼0.02% −22,100 Below 0.5%
2026-08-18 Morgan Stanley MUFG Securities Co., Ltd. Position 642,224 shares Ratio 0.60% ▲0.02% +18,800 —
2026-08-17 UBS AG Position 2,549,200 shares Ratio 2.38% ▼0.02% −13,400 —
2026-08-14 Morgan Stanley MUFG Securities Co., Ltd. Position 623,424 shares Ratio 0.58% ▼0.02% −26,300 —
2026-08-04 Morgan Stanley MUFG Securities Co., Ltd. Position 649,724 shares Ratio 0.60% ▲0.10% +113,500 —
2026-07-31 Morgan Stanley MUFG Securities Co., Ltd. Position 536,224 shares Ratio 0.50% ▲0.05% +16,184 —
2026-07-24 UBS AG Position 2,562,600 shares Ratio 2.40% ▲0.01% +8,300 —
2026-07-13 UBS AG Position 2,554,300 shares Ratio 2.39% ▼0.02% −19,600 —
2026-07-13 GOLDMAN SACHS INTERNATIONAL Position 541,300 shares Ratio 0.50% ▲0.08% +59,900 —
2026-07-08 UBS AG Position 2,573,900 shares Ratio 2.41% ▲0.02% +16,400 —
2026-07-06 UBS AG Position 2,557,500 shares Ratio 2.39% ▼0.01% −4,400 —
2026-05-20 UBS AG Position 2,561,900 shares Ratio 2.40% ▲0.10% +113,341 —
2026-05-13 Morgan Stanley MUFG Securities Co., Ltd. Position 520,040 shares Ratio 0.48% ▼0.07% −67,200 Below 0.5%
2026-05-07 GOLDMAN SACHS INTERNATIONAL Position 481,400 shares Ratio 0.45% ▼0.14% −151,400 Below 0.5%
2026-05-07 Morgan Stanley MUFG Securities Co., Ltd. Position 587,240 shares Ratio 0.55% ▼0.14% −148,000 —
2026-04-30 Morgan Stanley MUFG Securities Co., Ltd. Position 735,240 shares Ratio 0.69% ▼0.08% −87,400 —
2026-04-23 Morgan Stanley MUFG Securities Co., Ltd. Position 822,640 shares Ratio 0.77% ▲0.16% +167,400 —
2026-04-21 Morgan Stanley MUFG Securities Co., Ltd. Position 655,240 shares Ratio 0.61% ▲0.02% +22,200 —
2026-04-21 UBS AG Position 2,448,559 shares Ratio 2.30% ▲0.01% +313 —
2026-04-20 UBS AG Position 2,448,246 shares Ratio 2.29% ▼0.04% −35,254 —
2026-04-17 Morgan Stanley MUFG Securities Co., Ltd. Position 633,040 shares Ratio 0.59% ▼0.02% −26,600 —
2026-04-14 UBS AG Position 2,483,500 shares Ratio 2.33% ▲0.05% +46,600 —

Shorted Stocks in the Same Industry Pharmaceutical

Stock Estimated ratio Short sellers
GNI Group Ltd.2160 11.16% 7 firms
Oncolys BioPharma Inc.4588 10.35% 7 firms
HEALIOS K.K.4593 10.20% 5 firms
SymBio Pharmaceuticals Limited4582 9.46% 7 firms
Nxera Pharma Co.,Ltd.4565 7.35% 5 firms

Related Stocks Same TSE 33 sector

Stock Market TSE 33 Sector TOPIX-17 Sector Index
Veritas In Silico Inc.130A Growth Market(Domestic) Pharmaceutical Pharmaceutical
Chordia Therapeutics Inc.190A Growth Market(Domestic) Pharmaceutical Pharmaceutical
PRISM BioLab Co.,LTD206A Growth Market(Domestic) Pharmaceutical Pharmaceutical
GNI Group Ltd.2160 Growth Market(Domestic) Pharmaceutical Pharmaceutical
Heartseed Inc.219A Growth Market(Domestic) Pharmaceutical Pharmaceutical
Kyowa Kirin Co.,Ltd.4151 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
Takeda Pharmaceutical Company Limited4502 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Core30
K Pharma,Inc.4896 Growth Market(Domestic) Pharmaceutical Pharmaceutical
Innovacell Inc.504A Growth Market(Domestic) Pharmaceutical Pharmaceutical
J-Pharma Co.,Ltd.520A Growth Market(Domestic) Pharmaceutical Pharmaceutical